232 related articles for article (PubMed ID: 21351663)
1. [Contribution of whole-body magnetic resonance in the diagnostics of monoclonal gammopathy of undetermined significance, multiple myeloma, and the assessment of Durie-Salmon Plus staging system].
Scudla V; Herman M; Minarík J; Pika T; Hrbek J; Bacovský J; Heinzová V
Vnitr Lek; 2011 Jan; 57(1):52-60. PubMed ID: 21351663
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the serum levels of selected biological parameters in monoclonal gammopathy of undetermined significance and different stages of multiple myeloma.
Scudla V; Petrova P; Minarik J; Pika T; Bacovsky J
Neoplasma; 2011; 58(6):499-506. PubMed ID: 21895403
[TBL] [Abstract][Full Text] [Related]
3. Staging monoclonal plasma cell disease: comparison of the Durie-Salmon and the Durie-Salmon PLUS staging systems.
Fechtner K; Hillengass J; Delorme S; Heiss C; Neben K; Goldschmidt H; Kauczor HU; Weber MA
Radiology; 2010 Oct; 257(1):195-204. PubMed ID: 20851941
[TBL] [Abstract][Full Text] [Related]
4. [Analysis of serum levels of Dickkopf-1 (DKK-1) in monoclonal gammopathy of undetermined significance and multiple myeloma].
Ščudla V; Petrová P; Pika T; Lochman P; Minařík J; Bačovský J; Srovnalík K
Cas Lek Cesk; 2015; 154(4):181-8. PubMed ID: 26357861
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of serum levels of selected biological parameters in monoclonal gammopathy of undetermined significance and multiple myeloma].
Scudla V; Budíková M; Petrová P; Minarík J; Pika T; Bacovský J; Adamová D; Langová K;
Klin Onkol; 2010; 23(3):171-81. PubMed ID: 20608327
[TBL] [Abstract][Full Text] [Related]
6. Value of whole body MRI and dynamic contrast enhanced MRI in the diagnosis, follow-up and evaluation of disease activity and extent in multiple myeloma.
Dutoit JC; Vanderkerken MA; Verstraete KL
Eur J Radiol; 2013 Sep; 82(9):1444-52. PubMed ID: 23726124
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of focal lesions in whole-body magnetic resonance imaging in patients with asymptomatic multiple myeloma.
Hillengass J; Fechtner K; Weber MA; Bäuerle T; Ayyaz S; Heiss C; Hielscher T; Moehler TM; Egerer G; Neben K; Ho AD; Kauczor HU; Delorme S; Goldschmidt H
J Clin Oncol; 2010 Mar; 28(9):1606-10. PubMed ID: 20177023
[TBL] [Abstract][Full Text] [Related]
8. [Monoclonal gammopathy of undetermined significance].
Chaïbi P; Merlin L; Thomas C; Piette F
Ann Med Interne (Paris); 2002 Nov; 153(7):459-66. PubMed ID: 12598832
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
Kyle RA; Rajkumar SV
Hematol Oncol Clin North Am; 2007 Dec; 21(6):1093-113, ix. PubMed ID: 17996590
[TBL] [Abstract][Full Text] [Related]
10. [Multiple myeloma and idiopathic monoclonal gammapathy. Diagnosis, prognosis and treatment].
Bladé J
Med Clin (Barc); 1988 Apr; 90(17):704-14. PubMed ID: 3045448
[No Abstract] [Full Text] [Related]
11. Appearance of monoclonal plasma cell diseases in whole-body magnetic resonance imaging and correlation with parameters of disease activity.
Kloth JK; Hillengass J; Listl K; Kilk K; Hielscher T; Landgren O; Delorme S; Goldschmidt H; Kauczor HU; Weber MA
Int J Cancer; 2014 Nov; 135(10):2380-6. PubMed ID: 24706394
[TBL] [Abstract][Full Text] [Related]
12. [Contribution to the evaluation of serum levels of selected biological parameters in monoclonal gammopathy of undetermined significance and in individual clinical stages of multiple myeloma].
Scudla V; Petrová P; Minarík J; Pika T; Budíková M; Bacovský J; Repovský S
Vnitr Lek; 2010 Jun; 56(6):591-601. PubMed ID: 20681472
[TBL] [Abstract][Full Text] [Related]
13. The role of anatomic and functional staging in myeloma: description of Durie/Salmon plus staging system.
Durie BG
Eur J Cancer; 2006 Jul; 42(11):1539-43. PubMed ID: 16777405
[TBL] [Abstract][Full Text] [Related]
14. Comparison of whole-body diffusion MRI and conventional radiological assessment in the staging of myeloma.
Narquin S; Ingrand P; Azais I; Delwail V; Vialle R; Boucebci S; Tasu JP
Diagn Interv Imaging; 2013 Jun; 94(6):629-36. PubMed ID: 23683788
[TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance imaging as a supplement for the clinical staging system of Durie and Salmon?
Baur A; Stäbler A; Nagel D; Lamerz R; Bartl R; Hiller E; Wendtner C; Bachner F; Reiser M
Cancer; 2002 Sep; 95(6):1334-45. PubMed ID: 12216103
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal gammopathy of undetermined significance: why identification of these patients and assessment of their skeletons is important.
Berenson JR; Yellin O
Clin Lymphoma Myeloma; 2009 Aug; 9(4):311-5. PubMed ID: 19717382
[TBL] [Abstract][Full Text] [Related]
17. [Benign monoclonal gammopathy].
Shirota T; Kondo M; Uchida H; Ito H
Nihon Rinsho; 1995 Mar; 53(3):720-4. PubMed ID: 7699912
[TBL] [Abstract][Full Text] [Related]
18. [Monoclonal gammopathy of undetermined significance (MGUS): establishment of premyeloma concept].
Togawa A; Taniwaki M
Rinsho Ketsueki; 2002 Jul; 43(7):515-9. PubMed ID: 12229119
[No Abstract] [Full Text] [Related]
19. Multiple myeloma and monoclonal gammopathy of undetermined significance: importance of whole-body versus spinal MR imaging.
Bäuerle T; Hillengass J; Fechtner K; Zechmann CM; Grenacher L; Moehler TM; Christiane H; Wagner-Gund B; Neben K; Kauczor HU; Goldschmidt H; Delorme S
Radiology; 2009 Aug; 252(2):477-85. PubMed ID: 19703885
[TBL] [Abstract][Full Text] [Related]
20. [Multiple myeloma--diagnosis, prognostic factors and treatment].
Kitani T
Rinsho Ketsueki; 1995 May; 36(5):471-9. PubMed ID: 7783353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
